期刊文献+

人宫颈癌组织中survivin的表达与临床分析 被引量:6

The Expression and Clinical Analysis of surviving in Cervical Cancer Tissues
下载PDF
导出
摘要 目的:检测人宫颈正常组织、宫颈上皮内瘤变(Cervical intraepithelial neoplasia,CIN)以及宫颈癌组织中survivin蛋白的表达定位,研究该因子与宫颈癌发生发展的关系和临床应用价值。方法:收集2年间某医院97例患者的石蜡组织标本,其中正常宫颈组织20例、CIN25例、宫颈癌52例。采用免疫组化方法检测组织切片中的survivin蛋白,研究该因子在组织中的蛋白表达定位。结果:在宫颈组织中,survivin蛋白在胞核以及胞浆内均可见阳性染色,主要定位于细胞核。正常组survivin阳性率为5.0%,CIN组阳性率为56.0%,宫颈癌组阳性率为82.7%。survivin在宫颈癌组织中的高表达,与宫颈癌的临床分期、病理分化以及淋巴结转移均呈正相关。结论:survivin与宫颈癌的发生发展密切相关,可能成为对人宫颈癌的预防、诊治,以及判断预后有价值的临床肿瘤相关指标。 Objective:To observe the expression and location of survivin protein in human normal cervices,cervical intraepithelial neoplasia and cervical carcinoma,the relationship of survivin with the occurrence,development and prognostic of cervical carcinoma,and the clinical value of survivin for cervical carcinoma.Method:All of the paraffin tissue samples were gathered from one hospital in two years.The samples were divided three groups,20 cases of normal cervices,25 cases of cervical intraepithelial neoplasia,and 52 cases of cervical carcinoma.The stains of survivin protein in the tissue samples with the immunohistochemistry methods were checked.Result:The stains of survivin in cervical tissue samples were located in cell nucleus and cytoplasm,mainly in cell nucleus.The positive rate of survivin was 5.0% in normal cervices,56.0% in cervical intraepithelial neoplasia,82.7% in cervical carcinoma.The correlation could be found of survivin with the clinical stage,histological differentiation and lymphatic metastasis of the cervical carcinoma.Conclusion:The correlation can be find of survivin with the occurance and progression the cervical carcinoma closely.Survivin will be a clinic valuable marker for the prevention,diagnosis,treatment,and judging the prognosis of human cervical carcinoma.
出处 《中国医学创新》 CAS 2014年第6期36-39,共4页 Medical Innovation of China
关键词 宫颈癌 SURVIVIN 表达 Cervical carcinoma Survivin Expression
  • 相关文献

参考文献4

二级参考文献46

  • 1赵蕊,朱元莉,周羡梅,叶嗣懋,白若昀,耿力.子宫颈储备细胞增生与CD44v5在其细胞中的表达[J].解剖学报,2004,35(5):551-554. 被引量:8
  • 2郑金锋,马淑芳,耿明,曹永成,刘莹.p16和p15及PCNA在子宫颈癌组织中的表达及临床病理意义[J].中华肿瘤防治杂志,2007,14(4):291-293. 被引量:15
  • 3官立丽,彭芝兰,牛晓宇.HPV16 E6小干扰RNA与宫颈癌细胞中E6 p53 p21关系的研究[J].中国实用妇科与产科杂志,2007,23(7):517-519. 被引量:4
  • 4Schell W M, Janicek M F, Mirhashemi R. Epidemiology and bi ology of cervical cancer[J]. Semin Surg Oneol, 1999, 16(3):203-211.
  • 5Miehael F, Elka A, David O, et al. Immunohistochemical localization of survivin in benign eerdcal mucosa, cervical dysplasia, and invasive squamous cell carcinoma[J]. Am J Clin Pathol, 2002,117(5) :738.
  • 6Kim H S, Shiraki K, Park S H. Expression of survivin in CIN and invasive squamous cell carcinoma ofuterine cervix[J]. Antieancer Research, 2002, 22 (2) :805.
  • 7Ambrosch P, Schlott T, Hitmes D, et al. P16 alterations and retinohlastoma protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract[J]. Virchows Arch, 2001, 438(4): 343 349.
  • 8Ding L, Zou X J, Ao J E, et al. ELISA test to detect CDKN2A [p16(INK4a)] expression in exfoliative cells: a new screening tool for cervicalcancer[J]. MolDiagnTher, 2008, 12(6): 395-400.
  • 9Ozgul N, Cil A P, Bozdayi G. Staining characteristics of p16INK4A: is there a correlation with lesion grade or high-risk human papilloma virus positivity[J]. J Obstet Gynaecol Res,2008, 34(5):865-871.
  • 10Negn G, Egarter-Vigl E, kasal A, et al. p16^INK4A is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations[J]. Am J Surg Pathol, 2003, 27(2) : 187-193.

共引文献31

同被引文献50

  • 1王春燕.Survivin在宫颈癌组织中表达规律及临床意义[J].医学信息(医学与计算机应用),2014,0(11):215-216. 被引量:2
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 3Li F, ALTIERI DC. The cancer antiapoptosis mouse survivin gene characterization of locus and transcrip- tional requireiment of basal and cell cycle-dependent expnessionEJ-. Cancer , 1999,59(13) : 3143-3151.
  • 4MIRZA A, MCGUIRK M, HOCKENBERRY TN, et aL Human Survivinis negatively regulated by wild-type P53 and participates in P53-dependent apoptotic path- way [J],Oneogene, 2002,21(17)-2613-2633.
  • 5Klamura H, Torigoe T, Honma I, et al. Expression and antigenicity of survivin an inhibitor of apoptosis family member, in bladder cancer implication for spe- cific immunotherapy [J]. Urology, 2006, 67(9):955- 959.
  • 6Qian YB, Zhang JB, Wu WZ, et al. P48 is a predic- tive marker for outcome of postperative inter emn-al- pha treatment in patients with hepatitis B virus infec- tion-related hepatocellular carcinoma [ J ]. Cancer, 2006,107(7) : 1562-1569.
  • 7Ding SJ, Li Y, Tan YX, et al. From proteomic anal- ysis to clinical significance: overexpression of cytoker- atin 19 correlates with hepatocellular carcinoma metas- tasis [J]. Mol Cell Proteomics, 2004,3(1) :73-81.
  • 8顾桂芳,张美云,庄迅.宫颈癌组织中survivin基因表达的临床意义[J].南京医科大学学报(自然科学版),2008,28(2):232-235. 被引量:12
  • 9汤钊猷.从肝癌看癌症临床研究[J].肿瘤,2009,29(1):1-4. 被引量:42
  • 10李淼,闫风彩,钱智,刘勇.宫颈癌组织中Survivin、Ki-67及VEGF的表达及相关性[J].现代肿瘤医学,2011,19(7):1396-1399. 被引量:10

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部